Navigation Links
Study Cites Gains in Gall Bladder Cancer Treatment
Date:5/18/2009

Early detection, aggressive surgery boosts survival times, researchers say

MONDAY, May 18 (HealthDay News) -- Patients with gallbladder cancer are surviving longer than they used to, but the death rate is still high, new research shows.

An estimated 9,520 cases of gallbladder or bile duct cancer were diagnosed in the United States in 2008, and about 3,340 people died of the disease, according to the study in the May issue of the Archives of Surgery.

The death rate is high, in part, because at the time of diagnosis, many patients already have advanced-stage disease and are not candidates for surgery. Resection, where the diseased portions of the organ are removed surgically, is the only means of curing it.

"Gallbladder cancer is characterized by locally aggressive behavior, with early spread to regional lymph nodes and distant dissemination," the authors wrote. "In addition, it recurs rapidly even after presumed curative resection."

Still, survival times for the disease, which affects women more frequently than men, have improved since the 1960s.

Researchers from Harvard Medical School identified 402 patients with gallbladder cancer at a university-affiliated center between 1962 and 2008. Of these, 260 underwent surgical exploration at the same institution and were included in the data analysis.

Patients were diagnosed during three periods: period A (1962 to 1979), period B (1980 to 1997) and period C (1998 to 2008).

Overall median survival improved from 3.5 months during period A to six months in period B to one year in period C.

Survival times were the longest among those whose disease was caught early. The median survival was 10.3 months for those diagnosed with stage 2 cancer, compared to 4.7 months for stage 3 disease and 4 months for stage 4.

"The survival of patients who presented with advanced-stage disease and who underwent palliative [
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Mock CPR drills in kids show many residents fail in key skills, Hopkins study reveals
2. Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix for Treatment of Endometriosis Pain
3. Study finds higher prevalence of early menarche among survivors of childhood sexual abuse
4. Study: Smoking bans do not cause job losses in bars and restaurants
5. Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer
6. First-of-its-Kind Study Released at the SGNA 36th Annual Conference Reveals Inconsistency in GI Endoscope Reprocessing
7. Study sees transient heart dysfunction in some long-distance runners
8. Study tests the effect of ending ambulance diversion
9. Long-term study shows low oxygen levels in prostate tumors can predict recurrence
10. U.S. Study Shows Significant Improvement for Patients Suffering from Excessive Sweating with Topical Antiperspirant
11. BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Cites Gains in Gall Bladder Cancer Treatment
Study Cites Gains in Gall Bladder Cancer Treatment
Breaking Medicine Technology:Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 2Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 3Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 4Roche Diagnostics Opens State-of-the-Art Training Center in California 2Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 2Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 3Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 4Organization Announces End Prostate Cancer Tour 49229 1Organization Announces End Prostate Cancer Tour 49229 2Organization Announces End Prostate Cancer Tour 49229 3Ruben Studdard American Idol Winner and R 26B Pop Star Spreads the Word about Sickle Cell Disease and the Dangers of Iron Overload 49226 1Ruben Studdard American Idol Winner and R 26B Pop Star Spreads the Word about Sickle Cell Disease and the Dangers of Iron Overload 49226 2Ruben Studdard American Idol Winner and R 26B Pop Star Spreads the Word about Sickle Cell Disease and the Dangers of Iron Overload 49226 3AARP Others Push for Health Parity for Puerto Rico 49223 1AARP Others Push for Health Parity for Puerto Rico 49223 2